Randomized trial reveals improved tumor response through cancer immunotherapy, suggesting significant progress in treatment.
This year marks a turning point in cancer, as long-sought efforts to unleash the immune system against tumors are paying off—even if the future remains a question mark.
No takes yet. Share an insight, caveat, or question.
Jennifer Couzin-Frankel (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: